My scientific interests are guided by a desire to put an end to brain aging and Alzheimer’s disease. To that end, I plan to develop new high-sensitivity chemoproteomic methods and apply them to studies of (1) drug delivery across the blood-CSF barrier and (2) high-throughput structural biology of brain proteins during aging.